- Home
- APLM vs CJJD Comparison
APLM vs CJJD Comparison
Compare APLM & CJJD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- CJJD
- Stock Information
- Founded
- APLM 2016
- CJJD 2003
- Country
- APLM United States
- CJJD China
- Employees
- APLM N/A
- CJJD N/A
- Industry
- APLM Blank Checks
- CJJD Retail-Drug Stores and Proprietary Stores
- Sector
- APLM Finance
- CJJD Consumer Staples
- Exchange
- APLM Nasdaq
- CJJD Nasdaq
- Market Cap
- APLM 12.3M
- CJJD 11.2M
- IPO Year
- APLM N/A
- CJJD N/A
- Fundamental
- Price
- APLM $9.56
- CJJD $1.75
- Analyst Decision
- APLM Strong Buy
- CJJD
- Analyst Count
- APLM 2
- CJJD 0
- Target Price
- APLM $425.00
- CJJD N/A
- AVG Volume (30 Days)
- APLM 36.2K
- CJJD 17.4K
- Earning Date
- APLM 02-15-2025
- CJJD 07-30-2024
- Dividend Yield
- APLM N/A
- CJJD N/A
- EPS Growth
- APLM N/A
- CJJD N/A
- EPS
- APLM N/A
- CJJD N/A
- Revenue
- APLM $2,101,000.00
- CJJD $147,126,392.00
- Revenue This Year
- APLM N/A
- CJJD N/A
- Revenue Next Year
- APLM N/A
- CJJD N/A
- P/E Ratio
- APLM N/A
- CJJD N/A
- Revenue Growth
- APLM 70.54
- CJJD 3.85
- 52 Week Low
- APLM $6.50
- CJJD $1.34
- 52 Week High
- APLM $91.00
- CJJD $4.80
- Technical
- Relative Strength Index (RSI)
- APLM 46.48
- CJJD 42.25
- Support Level
- APLM $9.50
- CJJD $1.87
- Resistance Level
- APLM $10.67
- CJJD $1.97
- Average True Range (ATR)
- APLM 0.92
- CJJD 0.19
- MACD
- APLM -0.04
- CJJD -0.00
- Stochastic Oscillator
- APLM 13.17
- CJJD 16.55
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About CJJD China Jo-Jo Drugstores Inc. (Cayman Islands)
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.